University of California, Berkeley
Berkeley
California
94720
United States
284 articles about University of California, Berkeley
-
Vicinitas launched with a Series A round worth $65 million and was co-led by a16z and Deerfield Management, with participants including Droia Ventures, GV, and the Berkeley Catalyst Fund.
-
Novartis and UC Berkeley Extend Alliance to Tackle 'Undruggable' Disease Targets and Discover New Therapeutic Modalities
7/28/2022
Novartis and the University of California, Berkeley have extended their research-based collaboration to develop new technologies for the discovery of next-generation therapeutics, following its successes over the last five years.
-
What Makes Omicron More Infectious Than Other COVID-19 Variants
7/20/2022
As the Omicron variant of SARS-CoV-2 spread rapidly around the globe earlier this year, researchers at Gladstone Institutes, UC Berkeley, and the Innovative Genomics Institute used virus-like particles to identify which parts of the virus are responsible for its increased infectivity and spread.
-
Ansa Biotechnologies is advancing towards the launch of a customizable DNA synthesis service, stemming from the development of a novel synthesis method.
-
WIES fellows will have access to successful female entrepreneurs, including CRISPR pioneer and Nobel laureate Jennifer Doudna, who founded the IGI.
-
The U.S. Patent and Trademark Office ruled that the use of CRISPR-Cas9 in humans belongs to Broad, not UC Berkeley.
-
Arc begins its mission with $650 million in donations from donors. This funding will sustain the scientists and their researchers over renewable eight-year terms.
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
MiZ Company Limited Publishes Review Article on Discovery of Diatomic Molecule That Overcomes Diseases Caused by Chronic Inflammation, Incurable by Modern Medicine
9/29/2021
A paper titled "The overlooked benefits of hydrogen-producing bacteria. -Super beneficial Bacteria-," submitted by MiZ Company Limited and co-authored by the University of California, Berkeley, and Keio University, was accepted in Medical Gas Research on August 30, 2021.
-
Tempest Enters into Exclusive License Agreement with the University of California for Novel Cancer Target
9/13/2021
Tempest Therapeutics, Inc. announced that it has entered into an exclusive license with the University of California at Berkeley for intellectual property covering a drug target that was discovered in the laboratory of Russell Vance, Ph.D., professor of molecular and cell biology at U.C. Berkeley and a Howard Hughes Medical Institute investigator.
-
Forbes highlights its "30 Under 30" list who are beginning to make their mark in the biopharma and healthcare industries.
-
University of California, Berkeley, Study Confirms Efficacy of Prescription Drug Reference Pricing for Lowering Drug Costs for Employers and Patients
2/11/2020
Using ActiveRADAR’s Solution, Study Featured in JAMA Builds on Previous Research to Demonstrate Power of Reference Pricing to Decrease Prescription Drug Costs over Two and a Half- and Five-Year Time Frames
-
Ozone Exposure Associated with Asthma Symptoms
2/4/2020
Data from digital inhalers reveals an increased use of rescue inhalers for asthma symptoms due to short-term exposure to ozone, even below the ozone level set by the EPA
-
GNT Pharma's Anti-dementia Drug 'crisdesalazine' Demonstrates Efficacy in Phase III Clinical Study with Companion Dogs with Dementia
1/14/2020
GNT Pharma has successfully completed a Phase III clinical trial for crisdesalazine, a new drug for treating canine cognitive dysfunction syndrome or Alzheimer’s disease.
-
Weill Neurohub Will Promote Cross-Institutional Collaboration in Brain Trauma and Neurodegenerati...
11/13/2019
The Weill Family Foundation, University of California, Berkeley, University of California, San Francisco and the University of Washington launched the Weill Neurohub with a $106 million gift. -
NTT Research Partners with Simons Institute at UC Berkeley
11/6/2019
Industrial Partnership between NTT Research and the Simons Institute for the Theory of Computing Provides Framework for Collaboration
-
University of California expands U.S. CRISPR-Cas9 patent portfolio with issuance of new patent
10/1/2019
With its 16th U.S. patent, UC now holds largest U.S. CRISPR-Cas9 patent portfolio
-
USPTO awards 15th U.S. CRISPR-Cas9 patent to University of California
9/24/2019
New patent is fourth added to university's portfolio for the pioneering gene-editing technology this month
-
University of California adds new CRISPR-Cas9 patent to growing U.S. portfolio
9/17/2019
UC's U.S. CRISPR-Cas9 portfolio is most comprehensive for the gene-editing technology
-
University of California gains additional U.S. CRISPR-Cas9 patent related to single-guide RNA
9/10/2019
Second patent received this month related to sgRNAs for the groundbreaking gene-editing technology